Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (371-380 of 422) with videos related to

Pageof 43
Sort By:
Cancer Discovery|May 14, 2024
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to RadiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2004
Genetic and expression profiles of cerebellar liponeurocytomasSonja Horstmann, Arie Perry, Guido Reifenberger, et al.
Neuro-Oncology Advances|March 7, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survivalEduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, et al.
Acta Neuropathologica|April 13, 2016
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosisMartin Hasselblatt, Christian Thomas, Volker Hovestadt, et al.
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2022
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-GangliogliomaCalixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, et al.
Pageof 43

Showing results (371-380 of 422) with videos related to

Sort By:
Pageof 43
Cancer Discovery|May 14, 2024
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to RadiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2004
Genetic and expression profiles of cerebellar liponeurocytomasSonja Horstmann, Arie Perry, Guido Reifenberger, et al.
Neuro-Oncology Advances|March 7, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survivalEduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, et al.
Acta Neuropathologica|April 13, 2016
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosisMartin Hasselblatt, Christian Thomas, Volker Hovestadt, et al.
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2022
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-GangliogliomaCalixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, et al.
Pageof 43